Portfolio Update - Replacemen

RNS Number : 7504Q
Intl. Biotechnology Trust PLC
17 April 2009
 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the 'Company')    


Amending announcement


The Company advises that the following replaces the Portfolio Update announcement released erroneously on 16 April 2009 at 15.02 pm under RNS Number 6986Q.


Due to an administrative error, Gilead Sciences and Celgene appeared in the wrong order within the Top Ten Holdings. The heading of this table should have also been stated as Ten Largest Quoted Investments. All other details remain the same and the full corrected version of the announcement is shown below:        

    

                    

Portfolio update as at 31 March 2009                    



Total Net Asset Value ('NAV')

£92.3 million


                    

Ten Largest Quoted Investments

                                    

Company Name

NAV

Micromet

5.5

Celgene

5.3

Gilead Sciences

5.1

Amgen

4.6

Alexion Pharmaceuticals

3.4

Affymax

2.8

Wright Medical

2.8

Celera

2.7

OSI Pharmaceuticals

2.6

Halozyme Therapeutics

2.6


-----------

Total

37.4


Geographical Split

%

United States

81

Europe

15

Cash

4


-----------

Total

100


                                    

Unquoted/Quoted Split

%

Unquoted

26

Quoted

70

Cash

4


-----------


100

        



BNP Paribas Secretarial Services Limited

Company Secretary


17 APRIL 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUIRMLTMMABMPL
Investor Meets Company
UK 100